Share-based Compensation (Tables)

12 Months Ended

Jun. 30, 2020

Share-based Compensation

Schedule of weighted average assumptions

	2020			2019			2018
Risk-free interest rate		1.9	%		2.9	%		2.1	%
Expected volatility		73.7	%		58.4	%		57.6	%
Expected dividend yield		—	%		—	%		—	%
Forfeiture rate		—	%		6.5	%		6.5	%
Expected term		5.1	years		5.3	years		5.4	years
Weighted average fair value	$	4.0		$	6.52		$	11.25

Summary of stock option award activity

						Weighted
		Weighted-				Average
		Average		Aggregate		Remaining
		Exercise		Intrinsic		Contractual
(In thousands, except for weighted average price and life data)	Awards	Price		Value		Life (yrs.)
Outstanding at June 30, 2017	1,475	$	18.02	$	12,212	5.7
Granted	50	$	21.43
Exercised	(445)	$	7.23	$	4,243
Forfeited, expired or repurchased	(23)	$	30.83
Outstanding at June 30, 2018	1,057	$	22.46	$	2,584	5.4
Granted	73	$	12.20
Exercised	(94)	$	4.06	$	311
Forfeited, expired or repurchased	(464)	$	30.61
Outstanding at June 30, 2019	572	$	17.56	$	273	5.0
Granted	522	$	6.57
Exercised	(56)	$	5.42	$	237
Forfeited, expired or repurchased	(47)	$	24.73
Outstanding at June 30, 2020	991	$	12.11	$	678	5.6
Vested and expected to vest at June 30, 2020	989	$	12.10	$	678	5.6
Exercisable at June 30, 2020	493	$	16.82	$	371	2.3

Summary of non-vested restricted stock awards

		Weighted
		Average Grant -		Aggregate
(In thousands, except for weighted average price data)	Awards	date Fair Value		Intrinsic Value
Non-vested at June 30, 2017	334	$	30.71
Granted	641		18.01
Vested	(191)		31.30	$	4,104
Forfeited	(80)		20.95
Non-vested at June 30, 2018	704	$	20.06
Granted	1,176		9.90
Vested	(434)		19.75	$	4,107
Forfeited	(158)		14.00
Non-vested at June 30, 2019	1,288	$	11.63
Granted	941		6.45
Vested	(773)		10.54	$	6,401
Forfeited	(112)		10.75
Non-vested at June 30, 2020	1,344	$	8.70

Schedule of non-vested performance-based shares

		Weighted
		Average Grant -		Aggregate
(In thousands, except for weighted average price and life data)	Awards	date Fair Value		Intrinsic Value
Non-vested at June 30, 2017	—	$	—
Granted	47		25.58
Vested	(27)		25.58	$	574
Forfeited	—		—
Non-vested at June 30, 2018	20	$	25.58
Granted	52		17.69
Vested	—		—	$	—
Forfeited	—		—
Non-vested at June 30, 2019	72	$	19.92
Granted	178	$	10.71
Vested	(46)	$	15.08	$	477
Forfeited	—	$	—
Non-vested at June 30, 2020	204	$	12.99

Schedule of allocation of share-based compensation

	For Fiscal Year Ended June 30,
(In thousands)	2020		2019		2018
Selling, general and administrative expenses	$	7,087	$	5,715	$	7,570
Research and development expenses		801		750		680
Cost of sales		2,328		2,562		1,646
Total	$	10,216	$	9,027	$	9,896
Tax benefit at statutory rate	$	2,299	$	2,031	$	2,919